RVMD
Revolution Medicines, Inc.Company with tickers: RVMD, RVMDW
CIK
1628171
CUSIP
76155X100
Shares Outstanding
198,173,397
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-25 | Mancini Anthony | See Remarks | Sell | 1,800 |
| 2026-03-25 | Mancini Anthony | See Remarks | Convert | 37,450 |
| 2026-03-25 | Mancini Anthony | See Remarks | Convert | 37,450 |
| 2026-03-20 | Mancini Anthony | See Remarks | Other | 0 |
| 2026-03-20 | Mancini Anthony | See Remarks | Other | 54,400 |
| 2026-03-20 | Sandler Alan B. | Director | Other | 0 |
| 2026-03-20 | Sandler Alan B. | Director | Other | 53,000 |
| 2026-03-19 | Cislini Jeff | General Counsel | Sell | 1,163 |
| 2026-03-17 | GOLDSMITH MARK A | Director, See Remarks | Sell | 12,871 |
| 2026-03-17 | GOLDSMITH MARK A | Director, See Remarks | Other | 594,060 |
| 2026-03-17 | Horn Margaret A | Director | Sell | 4,583 |
| 2026-03-17 | Anders Jack | Chief Financial Officer | Sell | 2,753 |
| 2026-03-17 | Cislini Jeff | General Counsel | Sell | 1,795 |
| 2026-03-17 | Wang Xiaolin | See Remarks | Sell | 2,010 |
| 2026-03-17 | Wei Lin | Chief Medical Officer | Sell | 2,073 |
| 2026-03-17 | Kelsey Stephen Michael | See Remarks | Sell | 4,302 |
| 2026-03-04 | ANDERSON ELIZABETH M | Director | Gift | 15,000 |
| 2026-03-04 | ANDERSON ELIZABETH M | Director | Other | 26,990 |
| 2026-03-02 | GOLDSMITH MARK A | Director, See Remarks | Convert | 30,000 |
| 2026-03-02 | GOLDSMITH MARK A | Director, See Remarks | Convert | 30,000 |
| 2026-03-02 | GOLDSMITH MARK A | Director, See Remarks | Sell | 700 |
| 2026-03-01 | Wang Xiaolin | See Remarks | Award | 15,100 |
| 2026-03-01 | Wang Xiaolin | See Remarks | Award | 34,000 |
| 2026-03-01 | Wei Lin | Chief Medical Officer | Award | 15,100 |
| 2026-03-01 | Wei Lin | Chief Medical Officer | Award | 34,000 |
| 2026-03-01 | GOLDSMITH MARK A | Director, See Remarks | Other | 594,060 |
| 2026-03-01 | GOLDSMITH MARK A | Director, See Remarks | Award | 128,600 |
| 2026-03-01 | GOLDSMITH MARK A | Director, See Remarks | Award | 57,100 |
| 2026-03-01 | Cislini Jeff | General Counsel | Award | 14,500 |
| 2026-03-01 | Cislini Jeff | General Counsel | Award | 32,500 |
| 2026-03-01 | Kelsey Stephen Michael | See Remarks | Award | 47,600 |
| 2026-03-01 | Kelsey Stephen Michael | See Remarks | Award | 21,100 |
| 2026-03-01 | Horn Margaret A | Director | Award | 21,100 |
| 2026-03-01 | Horn Margaret A | Director | Award | 47,600 |
| 2026-03-01 | Anders Jack | Chief Financial Officer | Award | 45,400 |
| 2026-03-01 | Anders Jack | Chief Financial Officer | Award | 20,200 |
| 2026-02-06 | GOLDSMITH MARK A | Director, See Remarks | Other | 570,050 |
| 2026-02-06 | GOLDSMITH MARK A | Director, See Remarks | Convert | 24,010 |
| 2026-02-06 | GOLDSMITH MARK A | Director, See Remarks | Convert | 24,010 |
| 2026-01-21 | Cislini Jeff | General Counsel | Sell | 908 |
| 2026-01-07 | Horn Margaret A | Director | Convert | 51,406 |
| 2026-01-07 | Horn Margaret A | Director | Convert | 51,406 |
| 2026-01-07 | Horn Margaret A | Director | Sell | 53,096 |
| 2026-01-07 | Anders Jack | Chief Financial Officer | Convert | 10,000 |
| 2026-01-07 | Anders Jack | Chief Financial Officer | Sell | 10,000 |
| 2026-01-07 | Anders Jack | Chief Financial Officer | Convert | 10,000 |
| 2025-12-16 | Kelsey Stephen Michael | See Remarks | Sell | 5,447 |
| 2025-12-16 | Cislini Jeff | General Counsel | Sell | 2,688 |
| 2025-12-16 | Horn Margaret A | Director | Sell | 4,847 |
| 2025-12-16 | GOLDSMITH MARK A | Director, See Remarks | Other | 67,424 |
| 2025-12-16 | GOLDSMITH MARK A | Director, See Remarks | Sell | 15,394 |
| 2025-12-16 | Anders Jack | Chief Financial Officer | Sell | 3,104 |
| 2025-11-25 | GOLDSMITH MARK A | Director, See Remarks | Other | 570,050 |
| 2025-11-25 | GOLDSMITH MARK A | Director, See Remarks | Convert | 60,000 |
| 2025-11-25 | GOLDSMITH MARK A | Director, See Remarks | Sell | 60,000 |
| 2025-11-25 | GOLDSMITH MARK A | Director, See Remarks | Convert | 60,000 |
| 2025-11-25 | Anders Jack | Chief Financial Officer | Convert | 5,418 |
| 2025-11-25 | Anders Jack | Chief Financial Officer | Sell | 5,418 |
| 2025-11-25 | Anders Jack | Chief Financial Officer | Convert | 5,418 |
| 2025-11-18 | GOLDSMITH MARK A | Director, See Remarks | Sell | 20,000 |
| 2025-11-18 | GOLDSMITH MARK A | Director, See Remarks | Other | 70,424 |
| 2025-11-18 | GOLDSMITH MARK A | Director, See Remarks | Convert | 20,000 |
| 2025-11-18 | GOLDSMITH MARK A | Director, See Remarks | Convert | 20,000 |
| 2025-11-18 | Cislini Jeff | General Counsel | Convert | 13,388 |
| 2025-11-18 | Cislini Jeff | General Counsel | Convert | 13,388 |
| 2025-11-18 | Cislini Jeff | General Counsel | Sell | 13,388 |
| 2025-11-12 | GOLDSMITH MARK A | Director, See Remarks | Gift | 50,000 |
| 2025-11-12 | GOLDSMITH MARK A | Director, See Remarks | Sell | 20,000 |
| 2025-11-12 | GOLDSMITH MARK A | Director, See Remarks | Other | 70,424 |
| 2025-11-12 | GOLDSMITH MARK A | Director, See Remarks | Convert | 20,000 |
| 2025-11-12 | GOLDSMITH MARK A | Director, See Remarks | Convert | 20,000 |
| 2025-11-11 | Anders Jack | Chief Financial Officer | Convert | 10,000 |
| 2025-11-11 | Anders Jack | Chief Financial Officer | Convert | 10,000 |
| 2025-11-11 | Anders Jack | Chief Financial Officer | Sell | 10,000 |
| 2025-11-07 | GOLDSMITH MARK A | Director, See Remarks | Convert | 26,479 |
| 2025-11-07 | GOLDSMITH MARK A | Director, See Remarks | Convert | 26,479 |
| 2025-11-07 | GOLDSMITH MARK A | Director, See Remarks | Sell | 30,000 |
| 2025-11-07 | GOLDSMITH MARK A | Director, See Remarks | Other | 15,926 |
| 2025-10-17 | Cislini Jeff | General Counsel | Convert | 12,000 |
| 2025-10-17 | Cislini Jeff | General Counsel | Sell | 12,000 |
| 2025-10-17 | Cislini Jeff | General Counsel | Convert | 12,000 |
| 2025-10-17 | GOLDSMITH MARK A | Director, See Remarks | Sell | 10,000 |
| 2025-10-17 | GOLDSMITH MARK A | Director, See Remarks | Convert | 10,000 |
| 2025-10-17 | GOLDSMITH MARK A | Director, See Remarks | Convert | 10,000 |
| 2025-10-16 | GOLDSMITH MARK A | Director, See Remarks | Convert | 10,000 |
| 2025-10-16 | GOLDSMITH MARK A | Director, See Remarks | Convert | 10,000 |
| 2025-10-16 | GOLDSMITH MARK A | Director, See Remarks | Sell | 10,000 |
| 2025-10-16 | GOLDSMITH MARK A | Director, See Remarks | Other | 20,424 |
| 2025-10-13 | Kelsey Stephen Michael | See Remarks | Convert | 25,000 |
| 2025-10-13 | Kelsey Stephen Michael | See Remarks | Sell | 25,000 |
| 2025-10-13 | Kelsey Stephen Michael | See Remarks | Convert | 25,000 |
| 2025-09-24 | Cislini Jeff | General Counsel | Sell | 1,799 |
| 2025-09-16 | Wei Lin | Chief Medical Officer | Sell | 2,160 |
| 2025-09-16 | Kelsey Stephen Michael | See Remarks | Sell | 5,367 |
| 2025-09-16 | GOLDSMITH MARK A | Director, See Remarks | Sell | 13,411 |
| 2025-09-16 | GOLDSMITH MARK A | Director, See Remarks | Other | 20,424 |
| 2025-09-16 | Horn Margaret A | Director | Sell | 4,775 |
| 2025-09-16 | Cislini Jeff | General Counsel | Sell | 1,869 |
| 2025-09-16 | Anders Jack | Chief Financial Officer | Sell | 2,320 |
| 2025-09-15 | Kelsey Stephen Michael | See Remarks | Convert | 25,000 |